Ethics statement The studies involving human participants were reviewed and approved by Institutional Review Board at Nova Southeastern University in Fort Lauderdale, FL, USA
Incorrect dosing and unsafe escalation Lack of support in managing side effects such as nausea, dizziness, and digestive issues Exposure to unsafe or counterfeit products While the upfront cost looks cheaper, the long-term consequences can be both unsafe and ineffective
A trial of reperfusion therapy for ischemic stroke indicated that semaglutide, which has a strong GLP-1R-mediated neuroprotective effect, could reduce the infarct size in acute ischemic stroke in non-diabetic rats (89)
This advanced medication is especially beneficial for individuals who have struggled with other programs
Most feel completely normal
2 Treatment should be reviewed at 6 months, and NICE suggests considering stopping if less than 5% of the initial weight has been lost on the 2.4 mg dose